Physician profile
Mechery Davis
NPI 1407824477
$1,503.95
in general payments reported to CMS, 2019-2025
16 companies · $504 in 2025
The $504 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $15.45 · 2021: $158 · 2022: $150 · 2023: $123 · 2024: $301 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $928.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $238.72 | 2021-2024 | Xarelto |
| Phathom Pharmaceuticals, INC. | $232.78 | 2024-2025 | Voquezna |
| Pfizer INC. | $202.80 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $139.41 | 2023-2025 | Airsupra, Flumist Quadrivalent |
| Abbott Laboratories | $130.92 | 2022-2025 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $127.78 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.67 | 2019 | |
| Exact Sciences Corporation | $86.46 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $52.09 | 2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $49.28 | 2025 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $35.30 | 2023 | Gardasil 9, M-M-R II, Vaxelis |
| Amgen INC. | $31.02 | 2025 | Evenity |
| Tris Pharma INC | $18.09 | 2022 | |
| Abbvie INC. | $17.70 | 2025 | |
| Bausch Health US, LLC | $16.30 | 2025 | Wellbutrin |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $13.63 | 2025 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mechery Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.